When Chase Johnson was 31, her dog began acting strange.
Scientists have uncovered a powerful new antibody that disrupts a key protein helping triple-negative breast cancer survive and evade immunity. Triple-negative breast cancer (TNBC) is considered one ...
Cleveland Clinic researchers are presenting final Phase I data from their novel study of a vaccine aimed at preventing triple ...
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows ...
Findings set the stage for further investigation of hSFRP2 mAb as a targeted therapy for triple-negative breast cancer.
2don MSN
Cleveland Clinic researchers share promising results from experimental breast cancer vaccine trial
After decades of research, Phase 1 of a Cleveland Clinic study shows a breast cancer vaccine is safe and triggers an immune ...
News-Medical.Net on MSN
Cleveland Clinic reports promising results for breast cancer vaccine from final Phase 1 data
Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple ...
Friends, have you heard of triple-negative breast cancer [TNBC]? It’s a particularly aggressive type of breast cancer that ...
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the first ...
ROTTERDAM, the Netherlands, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Pan Cancer T B.V., a biotech company pioneering next-generation ...
At the San Antonio Breast Cancer Symposium (SABCS), investigators reported final phase I results of an alpha-lactalbumin (aLA ...
2don MSN
Breast Cancer: Triple-negative breast cancer vaccine shows promise in phase 1 clinical trial
A new vaccine targeting triple-negative breast cancer (TNBC) has shown promising results in its first human clinical trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results